Amifostine use in radiation-induced kidney damage: Preclinical evaluation with scintigraphic and histopathologic parameters

Strahlentherapie und Onkologie

Volumn 184, Issue 7, 2008, Pages 370-375

  Kaldir, Mine ^a   Cosar Alas, Rusen ^b   Cermik, Tevfik Fikret ^b   Yurut Caloglu, Vuslat ^b   Saynak, Mert ^b   Altaner, Semsi ^b   Caloglu, Murat ^b   Kocak, Zafer ^b   Tokatli, Fusun ^b   Türe, Mevlüt ^b   Parlar, Sule ^b   Uzal, Cem ^b  

^a MINISTRY OF HEALTH   (Turkey)

^b TRAKYA UNIVERSITY   (Turkey)

Author keywords

Amifostine; Kidney scintigraphy; Radiation late effects; Radiation nephropathy

Indexed keywords

2 (3 AMINOPROPYLAMINO)ETHANETHIOL; AMIFOSTINE; COBALT 60;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY SCINTISCANNING; KIDNEY TUBULE; NONHUMAN; RADIATION INJURY; RAT; RENAL PROTECTION;

AMIFOSTINE; ANIMALS; FEMALE; INJECTIONS, INTRAPERITONEAL; KIDNEY; KIDNEY FUNCTION TESTS; KIDNEY TUBULES; PREMEDICATION; RADIATION INJURIES; RADIATION-PROTECTIVE AGENTS; RADIONUCLIDE IMAGING; RATS; TECHNETIUM TC 99M DIMERCAPTOSUCCINIC ACID;

EID: 56549091749     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-008-1777-7     Document Type: Article

References (34)

1. Andratschke N, Schnaiter A, Weber WA, et al. Preclinical evaluation of erythropoietin administration in a model of radiation-induced kidney dysfunction. Int J Radiat Oncol Biol Phys 2006;64:1513-8.
2. Bohuslavizki KH, Brenner W, Klutmann S, et al. Radioprotection of salivary glands by amifostine in high-dose radioiodine therapy. J Nucl Med 1998;39:1237-42.
3. Bölling T, Schuck A, Rübe C, et al. [Therapy-associated late effects after irradiation of malignant diseases in childhood and adolescence. Feasibility analyses of a prospective multicenter register study.] Strahlenther Onkol 2006;182:443-9.
4. Brenner W, Kampen WU, Brummer C, et al. Myeloprotective effects of different amifostine regimens in rabbits undergoing high-dose treatment with 186rhenium-(tin)1,1-hydroxyethylidene diphosphonate (186Re-HEDP). Cancer Biother Radiopharm 2003;18:887-93.
5. Caglar M, Yaris N, Akyuz C. The utility of (99m)Tc-DMSA and Tc(99m)-EC scintigraphy for early diagnosis of ifosfamide induced nephrotoxicity. Nucl Med Commun 2001;22:1325-32.
6. Cassady JR. Clinical radiation nephropathy. Int J Radiat Oncol Biol Phys 1995;31:1249-56.
7. Cohen EP, Robbins ME. Radiation nephropathy. Semin Nephrol 2003;23:486-99.
8. De Lange MJ, Piers DA, Kosterink JG, et al. Renal handling of technetium-99m DMSA: evidence for glomerular filtration and peritubular uptake. J Nucl Med 1989;30:1219-23.
9. Dewit L, Anninga JK, Hoefnagel CA, et al. Radiation injury in the human kidney: a prospective analysis using specific scintigraphic and biochemical endpoints. Int J Radiat Oncol Biol Phys 1990;19:977-83.
10. Donaldson SS, Moskowitz PS, Evans JW, et al. Protection from radiation nephropathy by WR-2721. Radiat Res 1984;97:414-23.
11. Dörr W, Köst S, Keinert K, et al. Early intestinal changes following abdominal radiotherapy comparison of endpoints. Strahlenther Onkol 2006;182:1-8.
12. Fleischer G, Dörr W. Amelioration of early radiation effects in oral mucosa (mouse) by intravenous or subcutaneous administration of amifostine. Strahlenther Onkol 2006;182:567-75.
13. Foster-Nora JA, Siden R. Amifostine for protection from antineoplastic drug toxicity. Am J Health Syst Pharm 1997;54:787-800.
14. Kal HB, Loes van Kempen-Harteveld M, Heijenbrok-Kal MH, et al. Biologically effective dose in total-body irradiation and hematopoietic stem cell transplantation. Strahlenther Onkol 2006;182:672-9.
15. Kim TH, Freeman CR, Webster JH. The significance of unilateral radiation nephropathy. Int J Radiat Oncol Biol Phys 1980;6:1567-71.
16. Kost S, Dorr W, Keinert K, et al. Effect of dose and dose-distribution in damage to the kidney following abdominal radiotherapy. Int J Radiat Biol 2002;78:695-702.
17. Kost S, Keinert K. Kidney damage during radiotherapy of the para-aortic lymph nodes and spleen bed. Radiobiol Radiother (Berl) 1987;28:69-75.
18. Krochak RJ, Baker DG. Radiation nephritis. Clinical manifestations and pathophysiologic mechanisms. Urology 1986;27:389-93.
19. Kunkler PB, Farr RF, Luxton RW. The limit of renal tolerance to x-rays; an investigation into renal damage occurring following the treatment of tumours of the testis by abdominal bath. Br J Radiol 1952;25:192-201.
20. Le Bourgeois JP, Meignan M, Parmentier C, et al. Renal consequences of irradiation of the spleen in lymphoma patients. Br J Radiol 1979;52:56-60.
21. Lora-Michiels M, Anzola K, Amaya G, et al. Quantitative and qualitative scintigraphic measurement of renal function in dogs exposed to toxic doses of gentamicin. Vet Radiol Ultrasound 2001;42:553-61.
22. Mohr W, Wild A. Morphologic studies on rats with adjuvant disease of long duration. Z Rheumatol 1976;35:301-11.
23. Nevinny-Stickel M, Poljanc K, Forthuber BC, et al. Optimized conformal paraaortic lymph node irradiation is not associated with enhaced renal toxicity. Strahlenther Onkol 2007;183:385-91.
24. Potter R, Roes F, Schellong G, et al. Subclinical impairment of renal function after radiotherapy for Hodgkin's disease in children. Recent Results Cancer Res 1993;130:259-67.
25. Prager W, Merkelbach K. Long-term sequelae in the kidneys following abdominal irradiation of advanced malignant ovarian tumors. Radiobiol Radiother (Berl) 1986;27:341-5.
26. Risdon RA, Godley ML, Parkhouse HF, et al. Renal pathology and the 99mTc-DMSA image during the evolution of the early pyelonephritic scar: an experimental study. J Urol 1994;151:767-73.
27. Robbins ME, Zhao W. Chronic oxidative stress and radiation-induced late normal tissue injury: a review. Int J Radiat Biol 2004;80:251-9.
28. Takahashi I, Nagai T, Miyaishi K, et al. Clinical study of the radioprotective effects of amifostine (YM-08310, WR-2721) on chronic radiation injury. Int J Radiat Oncol Biol Phys 1986;12:935-8.
29. Treskes M, Boven E, Holwerda U, et al. Time dependence of the selective modulation of cisplatin-induced nephrotoxicity by WR-2721 in the mouse. Cancer Res 1992;52:2257-60.
30. Uzal C, Durmus-Altun G, Caloglu M, et al. The protective effect of amifostine on radiation-induced acute pulmonary toxicity: detection by (99m)Tc-DTPA transalveolar clearances. Int J Radiat Oncol Biol Phys 2004;60:564-9.
31. Weichert-Jacobsen KJ, Bannowski A, Kuppers F, et al. Direct amifostine effect on renal tubule cells in rats. Cancer Res 1999;59:3451-3.
32. White DC. The histopathologic basis for functional decrements in late radiation injury in diverse organs. Cancer 1976;37:Suppl:1126-43.
33. Williams MV, Denekamp J. Sequential functional testing of radiation-induced renal damage in the mouse. Radiat Res 1983;94:305-17.
34. Wollgens P, Albrecht HJ, Petschen I. Effect of renal radioisotope diagnostics on kidney parenchyma in patients with malignomas, following radiotherapy. Fortschr Geb Rontgenstr Nuklearmed 1971;114:415-21.